U.S. study finds Ozempic, Wegovy linked to increased risk of rare form of blindness
The study showed people with diabetes were more than four times more likely to be diagnosed with non-arteritic anterior ischemic optic neuropathy (NAION) if they were taking a prescription semaglutide and those who were overweight or obese were more